Drugs / Xiqing
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT07182942 | Jun 2024 → Nov 2025 overdue | chronic kidney disease | Chujin Cao | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Xiqing | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07182942 ↗ |
| Route | Oral | “oral intervention of Xiqing” NCT07182942 ↗ |